₹ 0.1 Cr
Volume Transacted
(Dec 20, 2024)
0.5 K
Stocks Traded
(Dec 20, 2024)
Last Updated on: Dec 22, 2024
Dr Lal Pathlabs Ltd
NSE: LALPATHLAB
ISIN
INE600L01024
Last updated on: Dec 22, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Dr Lal Pathlabs Ltd
NSE: LALPATHLAB
Share Price
₹ 2953.35
-67.15 (-2.22%)
Last updated on: Dec 20, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
20 Dec 2024 | 2953.35 | 3014.8 | 3028.1 | 2938.2 |
19 Dec 2024 | 3020.5 | 2989.05 | 3038.2 | 2989.05 |
18 Dec 2024 | 3038.15 | 3035 | 3065 | 3023.8 |
17 Dec 2024 | 3024.85 | 2990.1 | 3039.75 | 2987.3 |
16 Dec 2024 | 2984.05 | 2992.05 | 3025.85 | 2960 |
13 Dec 2024 | 3000.45 | 3035.05 | 3051.55 | 2995.25 |
12 Dec 2024 | 3040.4 | 3130.1 | 3165.05 | 3035 |
11 Dec 2024 | 3152.9 | 3179.7 | 3184.3 | 3140.25 |
10 Dec 2024 | 3164.05 | 3145.95 | 3206.9 | 3145.95 |
09 Dec 2024 | 3137.45 | 3070 | 3145 | 3026.9 |
Date | Price (₹) |
---|---|
20 Dec 2024 | 2953.35 |
19 Dec 2024 | 3020.5 |
18 Dec 2024 | 3038.15 |
17 Dec 2024 | 3024.85 |
16 Dec 2024 | 2984.05 |
13 Dec 2024 | 3000.45 |
12 Dec 2024 | 3040.4 |
11 Dec 2024 | 3152.9 |
10 Dec 2024 | 3164.05 |
09 Dec 2024 | 3137.45 |
Company Name | ISIN Code |
---|
Apollo Hospitals Enterprise Ltd | INE437A01024 |
Fortis Healthcare Ltd | INE061F01013 |
Syngene International Ltd | INE398R01022 |
Max Healthcare Institute Ltd | INE027H01010 |
Global Health Ltd | INE474Q01031 |
Company Name | ISIN Code |
---|---|
Apollo Hospitals Enterprise Ltd | INE437A01024 |
Fortis Healthcare Ltd | INE061F01013 |
Syngene International Ltd | INE398R01022 |
Max Healthcare Institute Ltd | INE027H01010 |
Global Health Ltd | INE474Q01031 |
Last updated time: 22 Dec 15:30 PM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Dr Lal Pathlabs Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Dr Lal Pathlabs Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Dr Lal Pathlabs allots 5,483 equity shares under ESOP
Dr Lal Pathlabs has allotted 5,483 equity shares under ESOP on 18 December 2024. Pursuant ...
18 Dec 2024 15:27
Dr Lal Pathlabs allots 3,000 equity shares under ESOP
Dr Lal Pathlabs has allotted 3,000 equity shares under ESOP on 05 December 2024. Pursuant ...
05 Dec 2024 18:16
Dr. Lal PathLabs allots Equity shares
Dr. Lal PathLabs approved allotment of 5,000 Equity Shares under the ESOP 2010 Plan of the...
30 Oct 2024 11:47
Board of Dr. Lal PathLabs recommends Second Interim dividend
Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held ...
23 Oct 2024 16:18
Dr. Lal PathLabs to declare Quarterly Result
Dr. Lal PathLabs will hold a meeting of the Board of Directors of the Company on 23 Octobe...
17 Oct 2024 15:53
Dr Lal Pathlabs allots 93,900 equity shares under ESOP
Dr Lal Pathlabs has allotted 93,900 equity shares under Dr. Lal PathLabs Employee Stock Op...
13 Aug 2024 09:10
Unlimited trading starting at just Rs. 249*